Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IGANGARGLE steroid gargling in IgA nephropathy
jRCTs031200127Completed
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of dexamethasone in IgA nephropathy (IgAN). Primary endpoint: Safety of steroid gargling. Started Jan 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on jRCTs031200127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200127.